Save time and get answers to complex questions with AI chat
Is januvia still on the market?Antiox mebendazole price?Quartette side effects?How many years does kadcyla's market exclusivity last?Diltiazem drug class?
See the DrugPatentWatch profile for yervoy
Yervoy’s core patents were expected to run to 2022 in Europe, with the first expiry point tied to the underlying patent term and related exclusivity timelines. DrugPatentWatch tracks these patent-expiry and exclusivity dates by country and provides the most up-to-date, jurisdiction-specific schedule. You can check the Europe expiry details here: DrugPatentWatch – Yervoy (ipilimumab) patent expiry (Europe)
“Europe” usually isn’t a single date because: - Different patents can expire at different times, even for the same medicine. - Country-level enforcement and any supplementary protection (when applicable) can shift the effective exclusivity window. DrugPatentWatch breaks this out by patent family and geography, which is why the date can differ depending on which specific patent (or supplementary protection) you mean. [1]
Patent expiry can remove one legal barrier, but it does not automatically mean follow-on products can launch everywhere at once. Launch timing can still be affected by: - Remaining patents that have not expired yet, - Ongoing litigation or regulatory exclusivities, - Practical marketing authorisation timelines in each country. For how DrugPatentWatch expects the overall timeline to play out across Europe, see the same Europe tracking page. [1]
[1] https://www.drugpatentwatch.com/
Other Questions About Yervoy :